The lifescience data mining and visualization market size has grown rapidly in recent years. It will grow from $4.21 billion in 2025 to $4.76 billion in 2026 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to growing volume of biological and clinical datasets, increased adoption of bioinformatics tools, expansion of pharmaceutical R&D activities, rising complexity of disease research, availability of high-performance computing infrastructure.
The lifescience data mining and visualization market size is expected to see rapid growth in the next few years. It will grow to $7.72 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to increasing investments in precision medicine research, rising adoption of ai-driven analytics platforms, growing demand for real-time clinical decision support, expansion of cloud-native life science software, increasing focus on personalized healthcare insights. Major trends in the forecast period include increasing adoption of advanced data visualization platforms, growing use of predictive analytics in life sciences, rising integration of multi-omics data sources, expansion of cloud-based data mining solutions, enhanced focus on real-time clinical data insights.
The growing demand for personalized medicine is expected to propel the growth of the life science data mining and visualization market going forward. Personalized medicine tailors treatment based on individual genetic and lifestyle factors, improving outcomes and reducing side effects. Life science data mining and visualization support this approach by converting complex biological data into actionable insights for precision care. For instance, in February 2024, the Personalized Medicine Coalition reported FDA approval of 16 personalized treatments in 2023, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the life science data mining and visualization market.
Leading companies operating in the life science data mining and visualization market are focusing on developing innovative products such as Platform-as-a-Service (PaaS) to integrate diverse real-world data sources, enable advanced analytics, and provide interactive visualization tools that support faster, data-driven decision-making across clinical, research, and commercial operations. Platform-as-a-Service (PaaS) refers to a cloud-based environment that provides developers and organizations with tools, infrastructure, and services to build, deploy, and manage applications without the complexity of managing underlying hardware or software. For instance, in February 2025, CitiusTech, a US-based health information technology company, launched CitiusTech HealthSPARX, an integrated real-world data (RWD) platform designed specifically for life sciences organizations to streamline data management and accelerate insights using advanced, AI-driven analytics. HealthSPARX enables seamless integration of diverse datasets that supports regulatory-grade analytics and promotes rapid, collaborative decision-making across clinical, research, and commercial operations.
In July 2024, Thermo Fisher Scientific Inc., a US-based science services company, acquired Olink Holding AB (publ) for approximately $3.1 billion. Through this acquisition, Thermo Fisher aims to integrate Olink’s advanced proteomics and biomarker discovery capabilities to strengthen its life sciences research and clinical diagnostics portfolio and improve scientific outcomes. Olink Holding AB is a Sweden-based life sciences company specializing in proteomics and biomarker data analysis.
Major companies operating in the lifescience data mining and visualization market are Microsoft Corporation, F. Hoffmann-La Roche Ltd., Oracle Corporation, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, SAP SE, Amgen Inc., GE Healthcare, IQVIA Holdings Inc., ICON plc, Agilent Technologies Inc., Dassault Systèmes SE, OpenText Corporation, Illumina Inc., Veeva Systems Inc., Palantir Technologies Inc., QIAGEN N.V., Flatiron Health Inc., LabWare Inc., Medable Inc.
North America was the largest region in the lifescience data mining and visualization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lifescience data mining and visualization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lifescience data mining and visualization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the life science data mining and visualization market by increasing costs of imported high-performance servers, data storage systems, advanced analytics software components, and visualization hardware. Research institutions, pharmaceutical companies, and healthcare providers in North America and Europe are most affected due to reliance on imported computing infrastructure, while Asia-Pacific faces higher costs for software licensing and system integration. These tariffs are increasing overall project costs and slowing platform upgrades. However, they are also encouraging regional data center investments, localized software development, and greater adoption of cloud-based analytics solutions that reduce dependence on imported hardware.
The lifescience data mining and visualization market research report is one of a series of new reports that provides lifescience data mining and visualization market statistics, including lifescience data mining and visualization industry global market size, regional shares, competitors with a lifescience data mining and visualization market share, detailed lifescience data mining and visualization market segments, market trends and opportunities, and any further data you may need to thrive in the lifescience data mining and visualization industry. This lifescience data mining and visualization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Life science data mining and visualization involve extracting meaningful patterns, correlations, and insights from extensive and complex biological and clinical datasets and presenting them through clear and interpretable visual formats. Its purpose is to speed up scientific discovery, support informed decision-making in research and healthcare, and deepen understanding of diseases, drug responses, and biological systems.
The primary component types of life science data mining and visualization include software and services. Software refers to specialized platforms and tools that enable extraction, analysis, and visualization of complex biological, clinical, and genomic data to support research and decision-making. These solutions utilize technologies such as machine learning, artificial intelligence, natural language processing, data visualization tools, and statistical analysis software and are deployed through on-premises, cloud-based, hybrid models, software as a service (SaaS), and platform as a service (PaaS). Applications include drug discovery, genomics and genetic research, clinical data analysis, patient health monitoring, and epidemiological studies, serving end-users such as pharmaceutical companies, biotechnology firms, contract research organizations (CROs), healthcare providers, and academic and research institutions.
The life science data mining and visualization market consists of revenues earned by entities by providing services such as training and support services for analytics platforms, custom visualization development services, and managed services for cloud-based platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The life science data mining and visualization market also includes sales of data integration platforms, bioinformatics pipelines, real-time monitoring platforms, and collaborative research portals. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The Life Science Data Mining and Visualization market is segmented by application, end-user, technology, data source, deployment mode, component, type, and product & services.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The lifescience data mining and visualization market size is expected to see rapid growth in the next few years. It will grow to $7.72 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to increasing investments in precision medicine research, rising adoption of ai-driven analytics platforms, growing demand for real-time clinical decision support, expansion of cloud-native life science software, increasing focus on personalized healthcare insights. Major trends in the forecast period include increasing adoption of advanced data visualization platforms, growing use of predictive analytics in life sciences, rising integration of multi-omics data sources, expansion of cloud-based data mining solutions, enhanced focus on real-time clinical data insights.
The growing demand for personalized medicine is expected to propel the growth of the life science data mining and visualization market going forward. Personalized medicine tailors treatment based on individual genetic and lifestyle factors, improving outcomes and reducing side effects. Life science data mining and visualization support this approach by converting complex biological data into actionable insights for precision care. For instance, in February 2024, the Personalized Medicine Coalition reported FDA approval of 16 personalized treatments in 2023, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the life science data mining and visualization market.
Leading companies operating in the life science data mining and visualization market are focusing on developing innovative products such as Platform-as-a-Service (PaaS) to integrate diverse real-world data sources, enable advanced analytics, and provide interactive visualization tools that support faster, data-driven decision-making across clinical, research, and commercial operations. Platform-as-a-Service (PaaS) refers to a cloud-based environment that provides developers and organizations with tools, infrastructure, and services to build, deploy, and manage applications without the complexity of managing underlying hardware or software. For instance, in February 2025, CitiusTech, a US-based health information technology company, launched CitiusTech HealthSPARX, an integrated real-world data (RWD) platform designed specifically for life sciences organizations to streamline data management and accelerate insights using advanced, AI-driven analytics. HealthSPARX enables seamless integration of diverse datasets that supports regulatory-grade analytics and promotes rapid, collaborative decision-making across clinical, research, and commercial operations.
In July 2024, Thermo Fisher Scientific Inc., a US-based science services company, acquired Olink Holding AB (publ) for approximately $3.1 billion. Through this acquisition, Thermo Fisher aims to integrate Olink’s advanced proteomics and biomarker discovery capabilities to strengthen its life sciences research and clinical diagnostics portfolio and improve scientific outcomes. Olink Holding AB is a Sweden-based life sciences company specializing in proteomics and biomarker data analysis.
Major companies operating in the lifescience data mining and visualization market are Microsoft Corporation, F. Hoffmann-La Roche Ltd., Oracle Corporation, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, SAP SE, Amgen Inc., GE Healthcare, IQVIA Holdings Inc., ICON plc, Agilent Technologies Inc., Dassault Systèmes SE, OpenText Corporation, Illumina Inc., Veeva Systems Inc., Palantir Technologies Inc., QIAGEN N.V., Flatiron Health Inc., LabWare Inc., Medable Inc.
North America was the largest region in the lifescience data mining and visualization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lifescience data mining and visualization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lifescience data mining and visualization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the life science data mining and visualization market by increasing costs of imported high-performance servers, data storage systems, advanced analytics software components, and visualization hardware. Research institutions, pharmaceutical companies, and healthcare providers in North America and Europe are most affected due to reliance on imported computing infrastructure, while Asia-Pacific faces higher costs for software licensing and system integration. These tariffs are increasing overall project costs and slowing platform upgrades. However, they are also encouraging regional data center investments, localized software development, and greater adoption of cloud-based analytics solutions that reduce dependence on imported hardware.
The lifescience data mining and visualization market research report is one of a series of new reports that provides lifescience data mining and visualization market statistics, including lifescience data mining and visualization industry global market size, regional shares, competitors with a lifescience data mining and visualization market share, detailed lifescience data mining and visualization market segments, market trends and opportunities, and any further data you may need to thrive in the lifescience data mining and visualization industry. This lifescience data mining and visualization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Life science data mining and visualization involve extracting meaningful patterns, correlations, and insights from extensive and complex biological and clinical datasets and presenting them through clear and interpretable visual formats. Its purpose is to speed up scientific discovery, support informed decision-making in research and healthcare, and deepen understanding of diseases, drug responses, and biological systems.
The primary component types of life science data mining and visualization include software and services. Software refers to specialized platforms and tools that enable extraction, analysis, and visualization of complex biological, clinical, and genomic data to support research and decision-making. These solutions utilize technologies such as machine learning, artificial intelligence, natural language processing, data visualization tools, and statistical analysis software and are deployed through on-premises, cloud-based, hybrid models, software as a service (SaaS), and platform as a service (PaaS). Applications include drug discovery, genomics and genetic research, clinical data analysis, patient health monitoring, and epidemiological studies, serving end-users such as pharmaceutical companies, biotechnology firms, contract research organizations (CROs), healthcare providers, and academic and research institutions.
The life science data mining and visualization market consists of revenues earned by entities by providing services such as training and support services for analytics platforms, custom visualization development services, and managed services for cloud-based platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The life science data mining and visualization market also includes sales of data integration platforms, bioinformatics pipelines, real-time monitoring platforms, and collaborative research portals. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The Life Science Data Mining and Visualization market is segmented by application, end-user, technology, data source, deployment mode, component, type, and product & services.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. LifeScience Data Mining and Visualization Market Characteristics
3. LifeScience Data Mining and Visualization Market Supply Chain Analysis
4. Global LifeScience Data Mining and Visualization Market Trends and Strategies
5. LifeScience Data Mining and Visualization Market Analysis of End Use Industries
7. Global LifeScience Data Mining and Visualization Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global LifeScience Data Mining and Visualization Total Addressable Market (TAM) Analysis for the Market
9. LifeScience Data Mining and Visualization Market Segmentation
10. LifeScience Data Mining and Visualization Market Regional and Country Analysis
11. Asia-Pacific LifeScience Data Mining and Visualization Market
12. China LifeScience Data Mining and Visualization Market
13. India LifeScience Data Mining and Visualization Market
14. Japan LifeScience Data Mining and Visualization Market
15. Australia LifeScience Data Mining and Visualization Market
16. Indonesia LifeScience Data Mining and Visualization Market
17. South Korea LifeScience Data Mining and Visualization Market
18. Taiwan LifeScience Data Mining and Visualization Market
19. South East Asia LifeScience Data Mining and Visualization Market
20. Western Europe LifeScience Data Mining and Visualization Market
21. UK LifeScience Data Mining and Visualization Market
22. Germany LifeScience Data Mining and Visualization Market
23. France LifeScience Data Mining and Visualization Market
24. Italy LifeScience Data Mining and Visualization Market
25. Spain LifeScience Data Mining and Visualization Market
26. Eastern Europe LifeScience Data Mining and Visualization Market
27. Russia LifeScience Data Mining and Visualization Market
28. North America LifeScience Data Mining and Visualization Market
29. USA LifeScience Data Mining and Visualization Market
30. Canada LifeScience Data Mining and Visualization Market
31. South America LifeScience Data Mining and Visualization Market
32. Brazil LifeScience Data Mining and Visualization Market
33. Middle East LifeScience Data Mining and Visualization Market
34. Africa LifeScience Data Mining and Visualization Market
36. LifeScience Data Mining and Visualization Market Competitive Landscape and Company Profiles
37. LifeScience Data Mining and Visualization Market Other Major and Innovative Companies
40. LifeScience Data Mining and Visualization Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
LifeScience Data Mining And Visualization Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses lifescience data mining and visualization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for lifescience data mining and visualization? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lifescience data mining and visualization market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Software; Services2) By Technology: Machine Learning Algorithms; Artificial Intelligence Tools; Natural Language Processing; Data Visualization Tools; Statistical Analysis Software
3) By Deployment Mode: On-Premises Solutions; Cloud-Based Solutions; Hybrid Deployment Models; Software As A Service (SaaS); Platform As A Service (PaaS)
4) By Application: Drug Discovery; Genomics And Genetic Research; Clinical Data Analysis; Patient Health Monitoring; Epidemiology Studies
5) By End-User: Pharmaceutical Companies; Biotechnology Firms; Clinical Research Organizations (CROs); Healthcare Providers; Research Institutions And Academic Entities
Subsegments:
1) By Software: Data Integration Software; Data Analysis And Statistical Software; Data Visualization Tools; Predictive Analytics Software; Machine Learning And Artificial Intelligence (AI) Platforms2) By Services: Data Management Services; Consulting And Advisory Services; Implementation And Integration Services; Training And Support Services
Companies Mentioned: Microsoft Corporation; F. Hoffmann-La Roche Ltd.; Oracle Corporation; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc; SAP SE; Amgen Inc.; GE Healthcare; IQVIA Holdings Inc.; ICON plc; Agilent Technologies Inc.; Dassault Systèmes SE; OpenText Corporation; Illumina Inc.; Veeva Systems Inc.; Palantir Technologies Inc.; QIAGEN N.V.; Flatiron Health Inc.; LabWare Inc.; Medable Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this LifeScience Data Mining and Visualization market report include:- Microsoft Corporation
- F. Hoffmann-La Roche Ltd.
- Oracle Corporation
- Thermo Fisher Scientific Inc.
- GlaxoSmithKline plc
- SAP SE
- Amgen Inc.
- GE Healthcare
- IQVIA Holdings Inc.
- ICON plc
- Agilent Technologies Inc.
- Dassault Systèmes SE
- OpenText Corporation
- Illumina Inc.
- Veeva Systems Inc.
- Palantir Technologies Inc.
- QIAGEN N.V.
- Flatiron Health Inc.
- LabWare Inc.
- Medable Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.76 Billion |
| Forecasted Market Value ( USD | $ 7.72 Billion |
| Compound Annual Growth Rate | 12.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
